Home initiation of apomorphine infusion: lessons from the COVID-19 pandemic and implications for current clinical practice

Feasibility and benefits of home initiation of subcutaneous apomorphine infusion for patients with Parkinson’s disease: the APOKADO study

(2023) Fabien Zagnoli et al.   JOURNAL OF NEURAL TRANSMISSION

Long-term safety and efficacy of apomorphine infusion in Parkinson's disease patients with persistent motor fluctuations: Results of the open-label phase of the TOLEDO study

(2021) Regina Katzenschlager et al.   PARKINSONISM & RELATED DISORDERS

An evaluation of subcutaneous apomorphine for the treatment of Parkinson’s disease

(2020) Thomas Müller   EXPERT OPINION ON PHARMACOTHERAPY

Continuous Dopaminergic Stimulation as a Treatment for Parkinson's Disease: Current Status and Future Opportunities

(2020) C. Warren Olanow et al.   MOVEMENT DISORDERS

Apomorphine subcutaneous infusion in patients with Parkinson's disease with persistent motor fluctuations (TOLEDO): a multicentre, double-blind, randomised, placebo-controlled trial

(2018) Regina Katzenschlager et al.   LANCET NEUROLOGY

Apomorphine - pharmacological properties and clinical trials in Parkinson's disease

(2016) Peter Jenner et al.   PARKINSONISM & RELATED DISORDERS

Expert Consensus Group report on the use of apomorphine in the treatment of Parkinson's disease – Clinical practice recommendations

(2015) Claudia Trenkwalder et al.   PARKINSONISM & RELATED DISORDERS